β1 integrins mediate cell proliferation in three-dimensional cultures by regulating expression of the sonic hedgehog effector protein, GLI1

Journal of Cellular Physiology

Volumn 224, Issue 1, 2010, Pages 210-217

  Goel, Hira Lal ^a   Underwood, Jean M ^a   Nickerson, Jeffrey A ^a   Hsieh, Chung Cheng ^a   Languino, Lucia R ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; GLI1 PROTEIN, HUMAN; HYBRID PROTEIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR; TYROSINE;

ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; CULTURE TECHNIQUE; GENETIC TRANSFECTION; GENETICS; HUMAN; MALE; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROSTATE TUMOR; RNA INTERFERENCE; TUMOR CELL LINE;

ERINACEIDAE;

ANTIGENS, CD29; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTEGRIN ALPHA5; MALE; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, IGF TYPE 1; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TYROSINE;

EID: 77952506397     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22116     Document Type: Article

References (36)

1. Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, Sawyer TK, Languino LR. 2007. The integrin-growth factor receptor duet. J Cell Physiol 213:649-653.
2. Blaess S, Graus-Porta D, Belvindrah R, Radakovits R, Pons S, Littlewood-Evans A, Senften M, Guo H, Li Y, Miner JH, Reichardt LF, Muller U. 2004. β1-integrins are critical for cerebellar granule cell precursor proliferation. J Neurosci 24:3402-3412.
3. Comoglio PM, Boccaccio C, Trusolino L. 2003. Interactions between growth factor receptors and adhesion molecules: Breaking the rules. Curr Opin Cell Biol 15:565-571.
4. Culig Z, Steiner H, Bartsch G, Hobisch A. 2005. Interleukin-6 regulation of prostate cancer cell growth. J Cell Biochem 95:497-505.
5. Eliceiri BP. 2001. Integrin and growth factor receptor crosstalk. Circ Res 89:1104-1110.
6. Felding-Habermann B. 2003. Integrin adhesion receptors in tumor metastasis. Clin Exp Metastasis 20:203-213.
7. Fornaro M, Tallini G, Zheng DQ, Flanagan WM, Manzotti M, Languino LR. 1999. p27(kip1) acts as a downstream effector of and is coexpressed with the β1C integrin in prostatic adenocarcinoma. J Clin Invest 103:321-329. (Pubitemid 29069981)
8. Fornaro M, Steger CA, Bennett AM, Wu JJ, Languino LR. 2000. Differential role of β1C and β1A integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways. Mol Biol Cell 11:2235-2249. (Pubitemid 30489911)
9. Goel HL, Fornaro M, Moro L, Teider N, Rhim JS, King M, Languino LR. 2004. Selective modulation of type 1 insulin-like growth factor receptor signaling and functions by β1 integrins. J Cell Biol 166:407-418.
10. Goel HL, Breen M, Zhang J, Das I, Aznavoorian-Cheshire S, Greenberg NM, Elgavish A, Languino LR. 2005. β1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts. Cancer Res 65:6692-6700.
11. Goel HL, Li J, Kogan S, Languino LR. 2008. Integrins in prostate cancer progression. Endocr Relat Cancer 3:657-664.
12. Goel HL, Alam N, Johnson IN, Languino LR. 2009a. Integrin signaling aberrations in prostate cancer. Am J Transl Res 1:211-220.
13. Goel HL, Moro L, Murphy-Ullrich JE, Hsieh CC, Wu CL, Jiang Z, Languino LR. 2009b. β1 Integrin cytoplasmic variants differentially regulate expression of the antiangiogenic extracellular matrix protein thrombospondin 1. Cancer Res 69:5374-5382.
14. Hynes RO. 2002. Integrins: Bidirectional, allosteric signaling machines. Cell 110:673-687.
15. Irie HY, Pearline RV, Grueneberg D, Hsia M, Ravichandran P, Kothari N, Natesan S, Brugge JS. 2005. Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol 171:1023-1034.
16. Karhadkar SS, Bova GS, Abdallah N, Dhara S, Gardner D, Maitra A, Isaacs JT, Berman DM, Beachy PA. 2004. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431:707-712.
17. Kasper M, Regl G, Frischauf AM, Aberger F. 2006. GLI transcription factors: Mediators of oncogenic Hedgehog signalling. Eur J Cancer 42:437-445.
18. Kim HJ, Litzenburger BC, Cui X, Delgado DA, Grabiner BC, Lin X, Lewis MT, Gottardis MM, Wong TW, Attar RM, Carboni JM, Lee AV. 2007. Constitutively active type I insulin-like growth factor receptor causes transformation and xenograft growth of immortalized mammary epithelial cells and is accompanied by an epithelial-to-mesenchymal transition mediated by NF-kappaB and snail. Mol Cell Biol 27:3165-3175.
19. Lauth M, Toftgard R. 2007. Non-canonical activation of GLI transcription factors: Implications for targeted anti-cancer therapy. Cell Cycle 6:2458-2463.
20. Liao X, Siu MK, Au CW, Wong ES, Chan HY, Ip PP, Ngan HY, Cheung AN. 2009. Aberrant activation of hedgehog signaling pathway in ovarian cancers: Effect on prognosis, cell invasion and differentiation. Carcinogenesis 30:131-140.
21. Litzenburger BC, Kim HJ, Kuiatse I, Carboni JM, Attar RM, Gottardis MM, Fairchild CR, Lee AV. 2009. BMS-536924 reverses IGF-IR-induced transformation of mammary epithelial cells and causes growth inhibition and polarization of MCF7 cells. Clin Cancer Res 15:226-237.
22. Majumder PK, Sellers WR. 2005. Akt-regulated pathways in prostate cancer. Oncogene 24:7465-7474.
23. 6 binds and activates latent TGFβ1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell 96:319-328.
24. Park CC, Zhang H, Pallavicini M, Gray JW, Baehner F, Park CJ, Bissell MJ. 2006. β1 Integrin inhibitory antibody induces apoptosis of breast cancer cells, inhibits growth, and distinguishes malignant from normal phenotype in three dimensional cultures and in vivo. Cancer Res 66:1526-1535.
25. Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. 2008. β1 Integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res 68:4398-4405.
26. Riobo NA, Lu K, Ai X, Haines GM, Emerson CP, Jr. 2006. Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling. Proc Natl Acad Sci USA 103:4505-4510.
27. Sachdev D, Yee D. 2007. Disrupting insulin-like growth factor signaling as a potential cancer therapy. Mol Cancer Ther 6:1-12.
28. Sanchez P, Hernandez AM, Stecca B, Kahler AJ, DeGueme AM, Barrett A, Beyna M, Datta MW, Datta S, Ruiz i Altaba A. 2004. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci USA 101:12561-12566.
29. Sanchez P, Clement V, Ruiz i Altaba A. 2005. Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer. Cancer Res 65:2990-2992.
30. Sasaki H, Hui C, Nakafuku M, Kondoh H. 1997. A binding site for Gli proteins is essential for HNF-3β floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 124:1313-1322. (Pubitemid 27190104)
31. Stecca B, Mas C, Ruiz i Altaba A. 2005. Interference with HH-GLI signaling inhibits prostate cancer. Trends Mol Med 11:199-203.
32. Tai YT, Podar K, Catley L, Tseng YH, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, Anderson KC. 2003. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of β1-integrin and phosphatidylinositol 3'-kinase/AKT signaling. Cancer Res 63:5850-5858.
33. Underwood JM, Imbalzano KM, Weaver VM, Fischer AH, Imbalzano AN, Nickerson JA. 2006. The ultrastructure of MCF-10A acini. J Cell Physiol 208:141-148.
34. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ. 1997. Reversion of the malignant phenotype of human breast cells in 3-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231-245.
35. Yanochko GM, Eckhart W. 2006. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells. Breast Cancer Res 8:R18.
36. Zhang X, Fournier MV, Ware JL, Bissell MJ, Yacoub A, Zehner ZE. 2009. Inhibition of vimentin or β1 integrin reverts morphology of prostate tumor cells grown in laminin-rich extracellular matrix gels and reduces tumor growth in vivo. Mol Cancer Ther 8:499-508.